Fine Organic Industries Ltd (FINEORG) Q1 FY27 Results Analysis: EBITDA Margin Beats Guidance, Revenue Grows 18% YoY
Fine Organic Industries Ltd's Q1 FY27 numbers came in strong, with revenue of Rs. 694.17 Cr (+18.00% YoY) and PAT growth of +18.00% YoY. Here's a quick read of what worked, what to watch, and what management said.
| Results date | August 07, 2026 |
|---|---|
| Quarter | Q1 FY 2026-2027 |
| Revenue (Q1) | Rs. 694.17 Cr (+18.00% YoY) |
| PAT (Q1) | Rs. 138.14 Cr (+18.00% YoY) |
| EBITDA margin | 25.35% (+435 bps YoY) |
| EPS (Q1) | Rs. 45.06 (+18.00% YoY) |
| Market cap | Rs. 15,813.83 Cr |
| CMP | Rs. 5,162.10 |
Quarter Snapshot
Revenue grew 18% YoY, driven by FX and price pass-through, in line with flat-volume guidance. EBITDA margin at 25.35% significantly exceeded the guided 18-20% range, aided by inventory buffer and FX tailwind, but is likely transitory. The company remains debt-free and announced an acquisition in Malaysia, but JV losses widened. The margin beat is a positive signal, though sustainability is uncertain.
Key Investment Insights
Key Positives
- Revenue grew 18% YoY to Rs.694.17 Cr, in line with the FX/price-driven guidance.
- EBITDA margin expanded 435 bps YoY to 25.35%, exceeding the guided 18-20% range.
- Consolidated PAT grew 18% YoY to Rs.138.14 Cr, with EPS at Rs.45.06.
- EBITDA surged 42% YoY to Rs.175.95 Cr, demonstrating operating leverage.
- Balance sheet remains debt-free; net worth of Rs.2,649.17 Cr (consolidated FY26).
- Acquisition of 80% stake in Oleofine Organics for Rs.82.86 Cr announced, expanding geographic footprint.
Risk Factors
- JV loss in Thailand widened to Rs.1.93 Cr from Rs.0.72 Cr YoY, a growing drag.
- EBITDA margin spike to 25.35% is likely transitory, partly due to inventory buffer and FX tailwind.
- Revenue growth is entirely FX/price-driven with no volume component, consistent with flat-volume guidance.
- Other income fell 39% YoY, partly due to base effect of insurance settlement in Q1 FY26.
Ask about this
Ask Cofacto a question about this result. Answers cite filings and company data.
Related
Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.